USD 1.36 billion
Global Epigenetics Market Size, Share, Growth Analysis, By Product type(Reagents, Kits), By Technology(DNA Methylation, Histone Methylation), By Application(Oncology, Cardiovascular Diseases) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2201 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
96 |
Figures:
76
Global Epigenetics Market Insights
Global Epigenetics Market size was valued at USD 1.36 billion in 2022 and is poised to grow from USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2031).
In recent years, the global Epigenetics market has been changing consumer preferences and demands due to the advancements in genomic research and a deeper understanding of epigenetic mechanisms.
Epigenetics, the study of heritable changes in gene function that do not involve alterations to the underlying DNA sequence, plays a crucial role in various biological processes and diseases.
The market is propelled by increasing applications in oncology, cardiology, neurology, and other therapeutic areas. DNA methylation, histone modification, and non-coding RNA regulation are key focuses in epigenetic research.
With a rising demand for personalized medicine and targeted therapies, the epigenetics market is expected to continue its expansion. Key players in the industry are investing in research and development to introduce innovative technologies and solutions, contributing to the overall growth and evolution of the global epigenetics market.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Reagents
Fastest Growth
Instruments
Growth Rate
14.8% CAGR
Global Epigenetics Market ($ Bn)
Country Share for North America Region (%)
Global Epigenetics Market By Type ($ Bn)
Global Epigenetics Market By Type(%)
To get more reports on the above market click here to Buy The Report
Global Epigenetics Market Segmental Analysis
The global epigenetics market is segmented into four major segments i.e. by product type, technology, application, and region. Based on type, it is divided into reagents, kits, instruments, enzymes, services. Based on technology, it is bifurcated as DNA methylation, histone methylation, histone acetylation, microrna modification, and other epigenetic modifications. Based on application it is segregated into, oncology, cardiovascular diseases, metabolic diseases, neurological disorders, immunology. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa..
Analysis by Type
Reagents have typically held a substantial market share as they are foundational components in epigenetic research, essential for processes like DNA methylation and histone modification analysis. Continuous demand for reagents in academic research, drug discovery, and diagnostic applications contributes to their dominance. Ongoing advancements in reagent formulations and functionalities enhance their utility in diverse epigenetic studies.
Epigenetic instruments are the fastest growing segment as technological advancements in epigenetic instruments, such as next-generation sequencing platforms and advanced analysis tools, drive increased adoption. Growing emphasis on high-throughput and automated epigenetic analysis boosts the demand for cutting-edge instruments. Instruments facilitate efficient and accurate epigenetic profiling, aligning with the expanding scope of research and diagnostic applications.
Analysis by Application
Oncology, commonly known as supermarkets, have long dominated the global Epigenetics market as epigenetic alterations play a crucial role in cancer development and progression, making oncology a prominent application area. Increased focus on precision medicine and targeted therapies drives the demand for epigenetic profiling in cancer diagnosis and treatment. Oncology research and clinical applications contribute significantly to the overall market, emphasizing the dominance of this segment.
The neurological disorders market’s fastest-growing segment due to the growing recognition of epigenetic mechanisms in neurological disorders, including Alzheimer's and Parkinson's diseases, fuels increased research and diagnostic efforts. Advancements in understanding the epigenetic basis of neurological disorders drive the development of targeted therapies and diagnostic tools. Emerging therapies that modulate epigenetic processes in neurology contribute to the rapid growth of this application segment.
Global Epigenetics Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Epigenetics Market Regional Insights
North America has historically dominated the epigenetics market due to the robust research infrastructure and significant funding for genomic and epigenetic research in countries like the United States contributing to North America's dominance. High prevalence of chronic diseases, coupled with a focus on precision medicine, drives the adoption of epigenetic technologies in research and clinical applications. The established presence of key market players and collaborations with research institutions further solidify North America's leading position.
Asia pacific is the fastest growing region due to the increasing research activities in countries like China, Japan, and India, driven by government initiatives and rising investments in life sciences, contributing to the region's rapid growth. Growing awareness of personalized medicine and the adoption of advanced technologies in healthcare drive the demand for epigenetic solutions. Emerging economies in the Asia-Pacific region are witnessing a surge in chronic diseases, creating opportunities for the application of epigenetics in diagnostics and therapeutics.
Global Epigenetics Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Epigenetics Market Dynamics
Drivers
Increasing Consumer Awareness on Epigenetic Mechanisms
- The increasing recognition of the pivotal role that epigenetic mechanisms play in regulating gene expression and influencing various biological processes. This heightened understanding has fueled a surge in research activities across academic, pharmaceutical, and biotechnology sectors, driving demand for epigenetic tools and technologies. Additionally, the rising incidence of chronic diseases, including cancer and neurological disorders, has intensified the focus on personalized medicine, where epigenetics plays a crucial role in tailoring treatment approaches.
Restraints
High Cost Associated with Advanced Epigenetic Technologies
- One of the main market restraints is the high cost associated with advanced epigenetic technologies, hindering widespread accessibility and adoption, particularly in resource-constrained regions. Ethical considerations and concerns related to data privacy in epigenetic research present regulatory challenges, impacting the pace of innovation. Additionally, the complexity of interpreting epigenetic data and the lack of standardized analytical methods pose obstacles to seamless integration into clinical practice.
Request Free Customization of this report to help us to meet your business objectives.
Global Epigenetics Market Competitive Landscape
The competitive environment of the epigenetics market is dynamic and characterized by the presence of key players and emerging entrants vying for market share. The players often engage in strategic collaborations and partnerships to enhance their market presence and foster innovation. Additionally, the market showcases a notable trend of partnerships between pharmaceutical companies and epigenetic solution providers, emphasizing the integration of epigenetics in drug discovery and development.
Top Player’s Company Profiles
- AbbVie Inc.
- AstraZeneca PLC
- Bayer AG
- BeiGene Ltd.
- Bristol Myers Squibb Company
- Epizyme, Inc.
- GlaxoSmithKline PLC
- Incyte Corporation
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Roche Holding AG
- Seattle Genetics, Inc.
- Takeda Pharmaceutical Company Limited
- Targovax, Inc.
- Vertex Pharmaceuticals Incorporated
- Vivid Biosciences Inc.
- Zymeworks Inc.
Recent Developments
-
In October 2023, FOXO Technologies Inc., a leader in the field of commercializing epigenetic biomarker technology, has announced plans for a new subscription-based, direct-to-consumer product offering that will provide personalized health and wellness recommendations. In connection with this, the Company also announced it has formed a collaboration with KR8.ai Inc. and secured an exclusive license to KR8’s AI-based software to support the development and commercial launch of the new health and wellness offering.
-
In October 2023, Zenith Epigenetics Ltd., a global leader in epigenetics, announced that it has entered into an agreement with Cencora for accelerating the commercialization of Zenith Epigenetics' ZEN-3694 program (an advanced epigenetic approach for advancing the efficacy of cancer treatment of currently marketed drugs). Existing partners and collaborators include Pfizer, Merck, BMS, Eli Lilly, Astellas, GSK, and Syndax and is supported by numerous collaborators and partners such as National Cancer Institute, National Institute of Health, Dana Farber-Harvard, Yale, UCSF, Memorial Sloan Kettering, and MD Anderson.
Global Epigenetics Key Market Trends
Rising Application of Epigenetic Insights
- The increasing application of epigenetic insights in personalized medicine, driving the development of targeted therapies for various diseases. The integration of artificial intelligence and machine learning in the analysis of vast epigenomic datasets is enhancing precision and efficiency in research endeavors. Moreover, there is a growing focus on non-invasive epigenetic diagnostics, utilizing technologies such as liquid biopsy for early detection of diseases like cancer. Epigenome editing technologies are gaining prominence, allowing researchers to modify specific epigenetic marks, opening new avenues for therapeutic interventions.
Global Epigenetics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global epigenetics market analysis reveals a dynamic marketplace with a number of standout trends and difficulties. The market is driven by an increasing understanding of epigenetic mechanisms and their role in disease, fostering research and technological advancements. High costs and ethical considerations serve as restraints, challenging widespread adoption. Product types, including reagents, kits, and instruments, play pivotal roles in advancing epigenetic research. North America dominates due to robust research infrastructure, while the Asia-Pacific region exhibits fast growth with rising research activities. Key trends involve personalized medicine applications, integration of AI in data analysis, and the emergence of non-invasive diagnostics, reflecting a dynamic and evolving landscape.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.36 billion |
| Market size value in 2031 | USD 4.7 billion |
| Growth Rate | 14.8% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Epigenetics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Epigenetics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Epigenetics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Epigenetics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Epigenetics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Epigenetics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Epigenetics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
